NIH Clinical Trials
ClinicalTrials.gov offers up-to-date information for locating federally and privately supported clinical trials for a wide range of diseases and conditions. A clinical trial (also clinical research) is a research study in human volunteers to answer specific health questions. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings.
ClinicalTrials.gov currently contains 131,478 trials sponsored by the National Institutes of Health, other federal agencies, and private industry. Studies listed in the database are conducted in all 50 States and in 179 countries and it receives over 50 million page views per month 65,000 visitors daily.
To review studies focused on vasculitis, enter the word “vasculitis” or the specific vasculitic disease in the Search box in the upper right hand corner.
Below is is a list of NIH Clinical Trials related to “vasculitis” last updated (includes received) in the last 30 days:
- Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment
- Treatment With Leflunomide in Patients With Polymyalgia Rheumatica
- NUCALA® Special Drug Use Investigation (EGPA, Long-term)
- Study of Refractory and/or Relapsing TAkayasu aRTeritis
- Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
- Phosphorylcholine PC-mAb Effects in Subjects With Elevated Lipoprotein a
- A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) – BLISS-BELIEVE
- Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography Angiography
- Interferon α2a Versus Cyclosporine for Refractory Behçet`s Disease Uveitis
- A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults